Piramal’s Pharma Solutions division has introduced a new ‘Proof of Concept’ service designed to bring the most promising ADC targets into clinical development more quickly. The company has recently made investments at its site in Grangemouth UK, and acquired Coldstream, a specialized ADC fill/finish site in Kentucky, as part of an effort to become a market leader in ADCs contract commercialization during the next five years.   Piramal sees the market for commercial ADCs accelerating in t...